Abstract
Currently, the use of adjuvant therapy for uveal melanoma is a wide-open question. To begin to answer the question, we need to define our high-risk population perhaps more uniformly using only genetic testing, utilize appropriate targets and implement thoughtful trial design.
| Original language | English (US) |
|---|---|
| Title of host publication | Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies |
| Publisher | Future Medicine Ltd. |
| Pages | 160-167 |
| Number of pages | 8 |
| ISBN (Print) | 9781780844268, 9781780844282 |
| DOIs | |
| State | Published - Jul 1 2014 |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Adjunctive treatment strategies for high-risk ocular melanoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS